Therapy of nontuberculous mycobacterial infections

Dermatologic Therapy

Volumn 17, Issue 6, 2004, Pages 491-498

  Jogi, Reena ^a,b   Tyring, Stephen K ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cutaneous; Infection; Mycobacteria; Therapy

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; ANTIMYCOBACTERIAL AGENT; AZITHROMYCIN; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ETHAMBUTOL; GAMMA INTERFERON; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; MACROLIDE; MINOCYCLINE; PYRIDOXINE; QUINOLONE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE;

BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; CRYOTHERAPY; DEBRIDEMENT; DRUG ACTIVITY; DRUG EFFICACY; DRUG SENSITIVITY; HUMAN; HYPERTHERMIC THERAPY; IRRADIATION; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM HAEMOPHILUM; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MARINUM; MYCOBACTERIUM SCROFULACEUM; MYCOBACTERIUM SIMIAE; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM ULCERANS; REVIEW; TUBERCULOSIS;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS, ATYPICAL; SKIN DISEASES, BACTERIAL;

EID: 10644221935     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1396-0296.2004.04051.x     Document Type: Review

References (51)

1. Runyon EH. Anonymous mycobacteria in pulmonary disease. Med Clin North Am 1959: 43: 273-290.
2. Buhler VB, Pollak A. Human infection with atypical acid-fast organisms: report of two cases with pathologic findings. Am J Clin Pathol 1953: 23: 363-374.
3. Fischer DA, Lester W, Schaefer WB. Infections with atypical mycobacteria: 5 years' experience at the National Jewish Hospital. Am Rev Resp Dis 1968: 98: 29-34.
4. Mayberry JD, Mullins JF, Stone OJ. Cutaneous infection due to Mycobacterium kansasii. JAMA 1965 December 6: 194: 1135-1137.
5. Callahan EF, Licata AL, Madison JF. Cutaneous Mycobacterium kansasii infection associated with a papulonecrotic tuberculid reaction. J Am Acad Dermatol 1997 March: 36: 497-499.
6. Hanke CW, Temofeew RK, Slama SL. Mycobacterium kansasii infection with multiple cutaneous lesions. J Am Acad Dermatol 1987 May: 16: 1122-1128.
7. Weitzul S, Eichhorn PJ, Pandya AG. Nontuberculous mycobacterial infections of the skin. Dermatol Clin 2000 April: 18: 359-377.
8. Griffith DE. Management of disease due to Mycobacterium kansasii. Clin Chest Med 2002 September: 23: 613-621.
9. Griffith DE, Brown-Elliott BA, Wallace RJ Jr. Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study. Clin Infect Dis 2003 November 1: 37: 1178-1182.
10. Wallace RJ Jr, Dunbar D, Brown BA, et al. Rifampin-resistant Mycobacterium kansasii. Clin Infect Dis 1994 May: 18: 736-743.
11. Linell F, Norden A. Mycobacterium balnei, a new acid-fast bacillus occurring in swimming pools and capable of producing skin lesions in humans. Acta Tuberc Scand Suppl 1954: 33: 1-84.
12. Jolly HW Jr, Seabury JH. Infections with Mycobacterium marinum. Arch Dermatol 1972: 106: 32-36.
13. Huminer D, Pitlik SD, Block C, et al. Aquarium-borne Mycobacterium marinum skin infection. Arch Dermatol 1986: 122: 698-703.
14. Gluckman SJ. Mycobacterium marinum. Clin Dermatol 1995 May-Jun: 13: 273-276.
15. Philpott JA, Woodburne AR, Philpott OS, et al. Swimming pool granuloma. Arch Dermatol 1963: 88: 94-98.
16. Travis WD, Travis LB, Roberts GD, et al. The histopathologic spectrum in Mycobacterium marinum infection. Arch Pathol Laboratory Med 1985: 109: 1109-1113.
17. Edelstein H. Mycobacterium marinum skin infections. Report of 31 cases and review of the literature. Arch Intern Med 1994 June 27: 154: 1359-1364.
18. Johnston JM, Izumi AK. Cutaneous Mycobacterium marinum infection ("swimming pool granuloma"). Clin Dermatol 1987: 5: 68-75.
19. Izumi AK, Hanke CW, Higaki M. Mycobacterium marinum infections treated with tetracycline. Arch Dermatol 1977 August: 113: 1067-1068.
20. Donta ST, Smith PW, Levitz RE, et al. Therapy of Mycobacterium marinum infections. Use of tetracyclines versus rifampin. Arch Intern Med 1986 May: 146: 902-904.
21. Huminer D, Pitlik SD, Block C, et al. Aquarium-borne Mycobacterium marinum skin infection. Report of a case and review of the literature. Arch Dermatol 1986 June: 122: 698-703.
22. Aubry A, Chosidow O, Caumes E, et al. Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. Arch Intern Med 2002 August 12-26: 162: 1746-1752.
23. Hautmann G, Lotti T. Diseases caused by Mycobacterium scrofulaceum. Clin Dermatol 1995 May-Jun: 13: 277-280.
24. Lai KK, Stottmeier KD, Sherman IH, et al. Mycobacterial cervical lymphadenopathy. Relation of etiologic agents to age. JAMA 1984 March 9: 251: 1286-1288.
25. Murray-Leisure KA, Egan N, Weitekamp MR. Skin lesions caused by Mycobacterium scrofulaceum. Arch Dermatol 1987 March: 123: 369-370.
26. Sowers WF. Swimming pool granuloma due to Mycobacterium scrofulaceum. Arch Dermatol 1972 May: 105: 760-761.
27. Hautmann G, Lotti T. Atypical mycobacterial infections of the skin. Dermatol Clin 1994 October: 12: 657-668.
28. Van der Werf TS, van der Graaf WT, Tappero JW, et al. Mycobacterium ulcerans infection. Lancet 1999 September 18: 354: 1013-1018.
29. Kullavanijaya P, Sirimachan S, Surarak S. Primary cutaneous infection with Mycobacterium avium intracellulare complex resembling lupus vulgaris. Br J Dermatol 1997 February: 136: 264-266.
30. Ichiki Y, Hirose M, Akiyama T, et al. Skin infection caused by Mycobacterium avium. Br J Dermatol 1997 February: 136: 260-263.
31. Sugita Y, Ishii N, Katsuno M, et al. Familial cluster of cutaneous Mycobacterium avium infection resulting from use of a circulating, constantly heated bath water system. Br J Dermatol 2000 April: 142: 789-793.
32. Kayal JD, McCall CO. Sporotrichoid cutaneous Mycobacterium avium complex infection. J Am Acad Dermatol 2002 November: 47: S249-S250.
33. Friedman BF, Edwards D, Kirkpatrick CH. Mycobacterium avium intracellulare: cutaneous presentations of disseminated disease. Am J Med 1988 August: 85: 257-263.
34. Cole GW, Gebhard J. Mycobacterium avium infection of the skin resembling lepromatous leprosy. Br J Dermatol 1979 July: 101: 71-74.
35. Wallace RJ, Glassroth J, Griffith DE, et al. Diagnosis and treatment of disease caused by nontuberculous Mycobacteria. Am. J. Respir. Crit. Care Medical 1997 August: 156 (Number 2): S1-S25.
36. Sompolinsky D, Lagziel A, Rosenberg I. Further studies of a new pathogenic mycobacterium (M. haemophilum sp. nov.). Can J Microbiol 1979 February: 25: 217-226.
37. Smith S, Taylor GD, Fanning EA. Chronic cutaneous Mycobacterium haemophilum infection acquired from coral injury. Clin Infect Dis 2003 October 1: 37: e100-101.
38. Geisler WM, Harrington RD, Wallis CK, et al. Broad spectrum of dermatologic manifestations caused by Mycobacterium haemophilum infection. Arch Dermatol 2002 February: 138: 229-230.
39. Shah MK, Sebti A, Kiehn TE, et al. Mycobacterium haemophilum in immunocompromised patients. Clin Infect Dis 2001 August 1: 33: 330-337.
40. Lin YC, Chiu HC, Hsiao CH, et al. Cutaneous Mycobacterium fortuitum infection mimicking lupus vulgaris. Br J Dermatol 2002 July: 147: 170-173.
41. Hand WL, Sanford JP. Mycobacterium fortuitum - a human pathogen. Ann Intern Med 1970 December: 73: 971-977.
42. Rosenmeier GJ, Keeling JH, Grabski WJ, et al. Latent cutaneous Mycobacterium fortuitum infection in a healthy man. J Am Acad Dermatol 1991 November: 25: 898-902.
43. Winthrop KL, Albridge K, South D, et al. The clinical management and outcome of nail salon-acquired Mycobacterium fortuitum skin infection. Clin Infect Dis 2004 January 1: 38: 38-44.
44. Wallace RJ Jr, Bedsole G, Sumter G. Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother 1990: 34: 65-70.
45. Sniezek PJ, Graham BS, Busch HB, et al. Rapidly growing mycobacterial infections after pedicures. Arch Dermatol 2003 May: 139: 629-634.
46. Wallace RJ Jr, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae. Importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antibiotics other then clarithromycin. J Infect Dis 1992: 166: 405-412.
47. Wallace RJ Jr. The clinical presentation, diagnosis, and therapy of cutaneous and pulmonary infections due to the rapidly growing mycobacteria: M. fortuitum M. chelonae. Clin Chest Med 1989 September: 10: 419-429.
48. Driscoll MS, Tyring SK. Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection. J Am Acad Dermatol 1997 March: 36: 495-496.
49. Fitzgerald DA, Smith AG, Lees A, et al. Cutaneous infection with Mycobacterium abscessus. Br J Dermatol 1995: 132: 800-804.
50. Morris-Jones R, Fletcher C, Morris-Jones T, et al. Mycobacterium abscessus: a cutaneous infection in a patient on renal replacement therapy. Clin Exp Dermatol 2001 July: 26: 415-418.
51. Colsky AS, Hanly A, Elgart G, et al. Treatment of refractory-disseminated Mycobacterium abscessus infection with interferon gamma therapy. Arch Dermatol 1999 February: 135: 125-127.